TD Asset Management
PFE icon

TD Asset Management’s Pfizer PFE Stock Holding History

TD Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$117M Buy
4,157,133
+261,508
+7% +$6.96M 0.09% 177
2025
Q4 		$97M Buy
3,895,625
+245,988
+7% +$6.2M 0.08% 200
2025
Q3 		$93M Sell
3,649,637
-28,692
-0.8% -$708K 0.08% 210
2025
Q2 		$89.2M Buy
3,678,329
+602,774
+20% +$14.1M 0.08% 213
2025
Q1 		$77.9M Buy
3,075,555
+318,629
+12% +$8.34M 0.07% 230
2024
Q4 		$73.1M Buy
2,756,926
+56,327
+2% +$1.53M 0.06% 248
2024
Q3 		$78.6M Buy
2,700,599
+117,725
+5% +$3.43M 0.07% 243
2024
Q2 		$72.3M Buy
2,582,874
+101,809
+4% +$2.8M 0.07% 241
2024
Q1 		$68.8M Buy
2,481,065
+67,917
+3% +$1.88M 0.06% 256
2023
Q4 		$69.5M Sell
2,413,148
-531,149
-18% -$16.1M 0.07% 241
2023
Q3 		$97.7M Sell
2,944,297
-458,930
-13% -$16.2M 0.12% 143
2023
Q2 		$125M Sell
3,403,227
-333,433
-9% -$13M 0.14% 127
2023
Q1 		$152M Sell
3,736,660
-5,242,825
-58% -$226M 0.18% 110
2022
Q4 		$460M Sell
8,979,485
-334,841
-4% -$16.1M 0.57% 38
2022
Q3 		$411M Sell
9,314,326
-72,055
-0.8% -$3.5M 0.52% 42
2022
Q2 		$492M Buy
9,386,381
+409,753
+5% +$20.9M 0.57% 39
2022
Q1 		$465M Buy
8,976,628
+1,169,738
+15% +$60.7M 0.43% 47
2021
Q4 		$461M Buy
7,806,890
+4,192,157
+116% +$208M 0.39% 56
2021
Q3 		$155M Buy
3,614,733
+250,758
+7% +$11.1M 0.16% 111
2021
Q2 		$144M Buy
3,363,975
+182,651
+6% +$7.1M 0.15% 120
2021
Q1 		$115M Buy
3,181,324
+16,106
+0.5% +$572K 0.13% 134
2020
Q4 		$117M Sell
3,165,218
-72,652
-2% -$2.66M 0.14% 132
2020
Q3 		$113M Sell
3,237,870
-2,116,689
-40% -$74.2M 0.16% 129
2020
Q2 		$166M Sell
5,354,559
-5,761,389
-52% -$196M 0.24% 88
2020
Q1 		$344M Buy
11,115,948
+1,179,475
+12% +$40.2M 0.58% 33
2019
Q4 		$369M Sell
9,936,473
-88,236
-0.9% -$3.14M 0.54% 39
2019
Q3 		$342M Buy
10,024,709
+205,318
+2% +$7.47M 0.52% 38
2019
Q2 		$404M Buy
9,819,391
+67,317
+0.7% +$2.67M 0.6% 30
2019
Q1 		$393M Buy
9,752,074
+557,450
+6% +$22.3M 0.6% 31
2018
Q4 		$381M Buy
9,194,624
+136,553
+2% +$5.67M 0.66% 26
2018
Q3 		$379M Sell
9,058,071
-289,721
-3% -$11.2M 0.56% 32
2018
Q2 		$322M Buy
9,347,792
+156,413
+2% +$5.35M 0.49% 38
2018
Q1 		$309M Buy
9,191,379
+745,415
+9% +$25.6M 0.47% 37
2017
Q4 		$290M Buy
8,445,964
+450,829
+6% +$15.4M 0.42% 45
2017
Q3 		$271M Buy
7,995,135
+2,666,151
+50% +$85.7M 0.41% 45
2017
Q2 		$170M Sell
5,328,984
-70,572
-1% -$2.23M 0.27% 73
2017
Q1 		$175M Buy
5,399,556
+371,969
+7% +$11.7M 0.28% 75
2016
Q4 		$155M Sell
5,027,587
-1,115,452
-18% -$34.1M 0.26% 79
2016
Q3 		$197M Buy
6,143,039
+22,974
+0.4% +$768K 0.34% 55
2016
Q2 		$204M Sell
6,120,065
-986,838
-14% -$31.5M 0.37% 54
2016
Q1 		$200M Buy
7,106,903
+370,263
+5% +$10.6M 0.37% 54
2015
Q4 		$206M Buy
6,736,640
+24,047
+0.4% +$756K 0.41% 50
2015
Q3 		$200M Buy
6,712,593
+66,522
+1% +$2.13M 0.39% 50
2015
Q2 		$211M Buy
6,646,071
+596,054
+10% +$19.4M 0.38% 50
2015
Q1 		$200M Sell
6,050,017
-148,536
-2% -$4.72M 0.36% 49
2014
Q4 		$183M Buy
6,198,553
+1,135,945
+22% +$32.6M 0.31% 57
2014
Q3 		$142M Buy
5,062,608
+144,562
+3% +$4.06M 0.25% 72
2014
Q2 		$138M Sell
4,918,046
-114,233
-2% -$3.26M 0.24% 74
2014
Q1 		$153M Sell
5,032,279
-2,298,369
-31% -$68.5M 0.28% 61
2013
Q4 		$213M Sell
7,330,648
-119,811
-2% -$3.49M 0.4% 47
2013
Q3 		$203M Sell
7,450,459
-324,471
-4% -$8.83M 0.4% 46
2013
Q2 		$207M Buy
+7,774,930
New +$215M 0.44% 45

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

TD Asset Management's PFE Position: Q1 2026 in Review

TD Asset Management increased its Pfizer (PFE) stake by 6.7% in Q1 2026, buying an estimated $6.96M and bringing the position to 4,157,133 shares worth $117M. The position accounts for 0.09% of the portfolio, ranked #177.

TD Asset Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $492M in Q2 2022. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • TD Asset Management held 4,157,133 shares of Pfizer worth $117M as of Q1 2026.
  • TD Asset Management bought 261,508 Pfizer shares in Q1 2026, an estimated $6.96M.
  • Pfizer made up 0.09% of TD Asset Management's portfolio in Q1 2026, its #177 holding.
  • TD Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • TD Asset Management's Pfizer position peaked at $492M in Q2 2022.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on TD Asset Management's 13F filing for Q1 2026, filed 11 May 2026.